New MRI scan could predict liver cancer in NASH patients
NCT ID NCT05165446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new, longer MRI scan that measures liver stiffness and viscosity to see if it can identify NASH patients at higher risk for liver cancer. About 35 adults with NASH and early-stage liver scarring will participate. The goal is to improve early detection, not to treat the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASH - NONALCOHOLIC STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford Hospital
Stanford, California, 94305, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could estrogen patch reverse liver damage in postmenopausal women?
- Experimental drug aims to reverse liver scarring in NASH cirrhosis
- New drug HPG1860 shows promise in reducing liver fat in NASH patients
- Hope for NASH: new pill aims to reverse liver damage and prevent cirrhosis
- Sleeve gastrectomy vs. lifestyle: which tames fatty liver disease?
- Can a keto diet help obese patients with advanced liver disease?